Home
|
Inbox
|
Search
|
Speaker
Craig S. Conoscenti
M.D.
Boehringer Ingelheim Pharmaceuticals Inc;Boehringer Ingelheim Pharmaceuticals Inc.
Session(s)
- Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF)...
Sunday, May 20 11:15 AM - 1:00 PM - Survival in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Regis...
Sunday, May 20 2:15 PM - 4:15 PM - Effect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (...
Monday, May 21 2:15 PM - 4:15 PM
|
Home
|
Inbox
|
Search
|